One hundred and twenty patients presenting with major peptic ulcer haemorrhage were randomised in a clinical trial comparing endoscopic injection and heater probe therapy. The two groups were well matched with regards to age, admission haemoglobin concentration, the presence of shock, non-steroidal antiinflammatory drug usage and endoscopic findings. Permanent haemostasis was achieved in 87% of the injection group and 85% of the heater probe group. Hospital mortality, transfusion requirement and duration of admission were similar in both groups. Endoscopic injection and the heater probe represent equally effective therapy for peptic ulcer bleeding.
Abstract
One hundred and twenty patients presenting with major peptic ulcer haemorrhage were randomised in a clinical trial comparing endoscopic injection and heater probe therapy. The two groups were well matched with regards to age, admission haemoglobin concentration, the presence of shock, non-steroidal antiinflammatory drug usage and endoscopic findings. Permanent haemostasis was achieved in 87% of the injection group and 85% of the heater probe group. Hospital mortality, transfusion requirement and duration of admission were similar in both groups. Endoscopic injection and the heater probe represent equally effective therapy for peptic ulcer bleeding. (Gut 1992; 33: 1159 -1161 The prognosis of patients presenting with bleeding peptic ulcer is improved by a range of therapeutic endoscopic techniques, but the best and most practical method is unclear. Endoscopic injection with adrenaline alone,'2 sclerosants,3 or a combination of the two4`is effective and cheap. Thermocoagulation using the heater probe performs better than endoscopic injections in experimental ulcer bleeding. 6 have a peptic ulcer which was either actively bleeding or which contained a nonbleeding protuberant vessel were entered into the study if they had at least one other risk factor. These risk factors were age over 60 years, initial haemoglobin concentration less than 100 g/l or shock, defined as a pulse rate greater than 100 beats/minute and/or a systolic blood pressure less than 100 mm Hg. A history of smoking, use of non-steroidal anti inflammatory drugs and evidence of major cardiorespiratory disease were recorded. Patients with known severe liver or renal disease, primary malignancy of the upper gastrointestinal tract or extensive metastatic disease were excluded.
Patients were randomised to endoscopic injection therapy or heater probe treatment by opening a sealed envelope (Table I) .
ENDOSCOPICTECHNIQUES: INJECTION THERAPY
Injection therapy was given using a disposable variceal injection needle (4 mm in length, 23 gauge, KeyMed Ltd, Southend-on-Sea). Four injections of 1:100 000 adrenaline to a maximum of 10 ml were placed around the ulcer. This invariably caused blanching and usually stopped active bleeding. A total of 0 5-2 ml of 5% ethanolamine was then injected around and into the bleeding area.
HEATER PROBE THERMOCOAGULATION
The Keymed Unit with 8F probe was used. After vigorous washing of the ulcer the probe was placed directly over the bleeding point and pulses of energy were given according to the tissue effect. A median of 225 joules (range 150 to 300) was used. 
Results
Two hundred and four patients were considered for inclusion into the study of whom 120 were randomised (60 to injection therapy, 60 to heater probe). The major reasons for exclusions were lack of endoscopic stigmata within a peptic ulcer (30 patients) and other causes of bleeding (54 patients). Five further patients had torrential peptic ulcer bleeding which obscured the bleeding area and prevented adequate diagnosis; all five were subjected to emergency surgery.
After randomisation endoscopic therapy was technically unsuccessful in five patients because the ulcer was inaccessible to injection (two patients) or the heater probe (three patients). The outcome of therapy, including these technical failures, is summarised in Table II . Eight patients (13%) in the injection group and nine (15%) in the heater probe group rebled. Four rebleeders from each group were retreated using the same treatment and one in each group responded and did not rebleed during their hospital admission. Fourteen of the remaining subjects who rebled were subjected to emergency surgery and one elderly high risk patient who rebled after initial heater probe treatment was successfully treated by arterial embolisation.
There were no differences in transfusion requirements or duration of hospital stay. No significant complications followed endoscopic therapy.
Mortality was similar in the two groups. All deaths were the result of postoperative complications of emergency surgery and occurred in elderly or frail subjects who had multiple medical problems.
Discussion
This randomised, prospective trial has shown similar efficacy for endoscopic injection and heater probe therapy in patients presenting with major peptic ulcer haemorrhage. Our hospital mortality of 4% is acceptable because this subgroup represents approximately 30% of all patients admitted with peptic ulcer bleeding. The remaining 70% have more modest bleeding, unassociated with endoscopic stigmata and have an excellent prognosis.T his study differs in several respects from those reported by other centres. Chung et aP studied only actively bleeding patients and found that initial haemostasis was better with adrenaline injection therapy than with the heater probe. In the subgroup of patients presenting to us with active haemorrhage we also found haemostasis to be more easily achieved using adrenaline although the prognosis in our hands was similar using either technique. In the study reported by Chung et al, the eventual outcome was similar in both groups suggesting that the advantage of better acute haemostasis with injection therapy was balanced by a lower rebleeding rate in the heater probe group. This suggests that the acute vasoconstricting action of dilute adrenaline was not followed by arterial thrombosis and an optimum therapy may be a combination of an adrenaline injection which will stop active bleeding, followed by heater probe treatment causing arterial damage, thrombosis and prevention of rebleeding. Our study used injection therapy with adrenaline and ethanolamine, which was designed to produce an acute vasoconstrictor effect and endarteritis leading to a reduced risk of rebleeding, and this combination was compared with the heater probe.
The 
